Sodium Oxybate
Brand name: Xyrem
Rank #313 of 500 drugs by total cost
$35.8M
Total Cost
2,160
Total Claims
$35.8M
Total Cost
149
Prescribers
$17K
Cost per Claim
0
Beneficiaries
2,160
30-Day Fills
$240K
Avg Cost/Provider
14
Avg Claims/Provider
About Sodium Oxybate
Sodium Oxybate (sold as Xyrem) was prescribed 2,160 times by 149 Medicare Part D providers in 2023, costing the program $35.8M. At $17K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 310 | Alprazolam (Alprazolam) | $36.1M | 4,899,372 |
| 311 | Naloxegol Oxalate (Movantik) | $36.1M | 85,094 |
| 312 | Valacyclovir Hcl (Valacyclovir) | $35.9M | 827,731 |
| 313 | Sodium Oxybate (Xyrem) | $35.8M | 2,160 |
| 314 | Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate) | $35.7M | 88,692 |
| 315 | Ketoconazole (Ketoconazole) | $35.4M | 1,346,512 |
| 316 | Oxcarbazepine (Oxcarbazepine) | $35.3M | 430,248 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology